Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Share News (DVO)

  • There is currently no data for DVO

Non-execs show confidence in Devro

Tue, 22nd Feb 2011 16:53
Buying by Devro directors has kept the share price rising after yesterday's annual results from the sausage casings manufacturer. The shares rose a further 9% to 265.1p each. Chairman Steve Hannam bought 16,616 shares at 240p each, taking his stake to 149,306. The total investment was nearly £39,000. Hannam has been chairman since May 2009. Non-executive director Paul Neep acquired 6,070 shares at 241p each, which cost £14,629. He owns 193,593 shares in Devro. Neep, who is chief executive of LVMH subsidiary Glenmorangie, has been on the board since 2005. Devro's profit before tax and exceptional items in 2010 rose 44% to £36.3m. Reported profit before tax doubled to £55.2m from £26.9m, as 2010's results benefited from an £18.9m exceptional credit derived from a reduction in the liabilities of the group's UK defined benefit pension scheme. Operating margin improved to 16.1% from 12.4%, reflecting higher prices and a more efficient manufacturing cost base.Panmure Gordon raised its 2011 profit forecast after the figures. The earnings per share forecast was increased from 18.1p to 19.5p. Top Director BuysDevro (DVO) Director name: Mr Steve HannamAmount purchased: 16,616 @ 240.00pValue: £39,878Devro (DVO) Director name: Mr Paul NeepAmount purchased: 6,070 @ 241.00Value: £14,629Top Director SellsCarnival (CCL) Director name: Mr Peter RatcliffeAmount sold: 22,909 @ 2,838.95p Value: £650,375Carnival (CCL) Director name: Mr Pier Luigi FoschiAmount sold: 16,593 @ 2,838.95p Value: £471,067GlaxoSmithKline (GSK) Director name: Mr Simon BicknellAmount sold: 1,286 @ 1,201.00p Value: £15,445Europa Oil & Gas (EOG) Director name: Mr Paul A BarrettAmount sold: 25,000 @ 41.64p Value: £10,410Europa Oil & Gas (EOG) Director name: Mr Paul A BarrettAmount sold: 25,000 @ 41.62p Value: £10,405

Related News

GSK says US FDA approves urinary tract infection treatment Utebzi
2 hours ago

GSK says US FDA approves urinary tract infection treatment Utebzi

(Alliance News) - GSK PLC and Spero Therapeutics Inc on Wednesday said that the US Food & Drug Administration has approved Utebzi, an oral antibiotic ...

GSK drug momelotinib gains regulatory nods as VEXAS treatment
5 days ago

GSK drug momelotinib gains regulatory nods as VEXAS treatment

(Alliance News) - GSK PLC on Friday announced that momelotinib has received orphan drug designation from the US Food & Drug Administration, and the Eu...

GSK's momelotinib receives orphan drug designation from US and EU watchdogs
5 days ago

GSK's momelotinib receives orphan drug designation from US and EU watchdogs

(Sharecast News) - Drugmaker GSK said on Friday that its JAK inhibitor momelotinib has been granted orphan drug designation by both the US Food and Dr...

DVO.L News

UK Dividends Calendar - Next 7 Days
25 Sep 2020

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days
13 Aug 2020

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Devro sees strong 1H sales in emerging markets, pays out 2019 dividend
29 Jul 2020

Devro sees strong 1H sales in emerging markets, pays out 2019 dividend

(Sharecast News) - Devro saw first half sales dip as the Covid-19 pandemic dented its sales momentum, offset by a solid performance in emerging market...

Devro's Interim Growth Stifled By Covid-19 And Coats Pinches CFO
29 Jul 2020

Devro's Interim Growth Stifled By Covid-19 And Coats Pinches CFO

Devro's Interim Growth Stifled By Covid-19 And Coats Pinches CFO

LONDON BRIEFING: Barclays Starts UK Bank Reporting With Halved Profit
29 Jul 2020

LONDON BRIEFING: Barclays Starts UK Bank Reporting With Halved Profit

LONDON BRIEFING: Barclays Starts UK Bank Reporting With Halved Profit

UK Earnings, Trading Statements Calendar - Next 7 Days
22 Jul 2020

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

UK DIRECTOR DEALINGS SUMMARY: Silence CFO Sells GBP360,000 Worth
12 May 2020

UK DIRECTOR DEALINGS SUMMARY: Silence CFO Sells GBP360,000 Worth

UK DIRECTOR DEALINGS SUMMARY: Silence CFO Sells GBP360,000 Worth

UK Dividends Calendar - Next 7 Days
30 Apr 2020

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days